OraSure Technologies | OSUR - 流动负债



金融业
股票价格
USD
资产
USD 379.17M
现金及等价物
USD 176.96M
销售成本
USD 15.43M
流动资产
USD 240.78M
流动负债
USD 44.08M
债务
USD 782K
股息收益率
0
EBIT
USD -13.59M
EBITDA
USD -17.7M
员工
638
EPS每股收益
USD -0.18
股本和储备
USD 313.32M
销售毛利
USD 11.34M
债务利息支出
1.67M
贷款资金
USD 100K
市值
USD 308.5M
净收入
USD -19.29M
营业费用
USD 40.35M
营业利润
USD -13.59M
普通股股本
USD 70.39M
PE价格收益
24.42
税前利润
USD -18.43M
销售收入
USD 26.76M
销售和管理费用
USD 13.21M
股票
USD 30.31M
贸易债权人
USD 10.63M
应收帐款人
USD 22.2M


流动负债 更改 日
Agilent USD 2.27B 35M 2026-03
AngioDynamics USD 71.96M 3.68M 2025-09
Becton, Dickinson and Co. USD 8.51B 254M 2026-03
Bio Techne USD 153.28M 12.85M 2026-03
Bio-Rad Laboratories USD 917M 400M 2026-03
Bruker USD 1.36B 75.9M 2026-03
Cerus USD 100.8M 12.37M 2025-12
Charles River Laboratories USD 1.09B 26.61M 2026-03
Danaher USD 7.46B 653M 2026-03
Dentsply International USD 1.21B 136M 2026-03
Dexcom USD 2.22B 81.3M 2026-03
Illumina USD 1.57B 19M 2026-03
Integra LifeSciences USD 346.85M 109.14M 2026-03
Intuitive Surgical USD 2.51B 3.2M 2026-03
IQVIA Holdings USD 8.33B 9M 2026-03
Mesa Laboratories USD 54.4M 6.1M 2025-12
Mettler Toledo International USD 1.11B 89.76M 2026-03
Myriad Genetics USD 130.2M 3.6M 2026-03
OraSure Technologies USD 44.08M 4.29M 2026-03
Quidel USD 962.4M 3.7M 2026-03
Repligen USD 126.21M 9.62M 2026-03
Revvity USD 1.24B 92.6M 2026-03
STAAR Surgical USD 60.99M 7.51M 2026-03
Thermo Fisher Scientific USD 14.62B 568M 2026-03
Trinity Biotech USD 34.49M 2.97M 2025-09
Waters USD 1.24B 11.8M 2025-12